| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.86▲ | 0.86▲ | 0.86▲ | 0.87▼ | 0.96▼ |
| MA10 | 0.87▼ | 0.87▼ | 0.87▼ | 0.92▼ | 1.00▼ |
| MA20 | 0.90▼ | 0.91▼ | 0.92▼ | 0.97▼ | 1.51▼ |
| MA50 | 1.03▼ | 1.03▼ | 1.02▼ | 1.03▼ | 2.29▼ |
| MA100 | 1.04▼ | 0.98▼ | 0.97▼ | 1.55▼ | 13.91▼ |
| MA200 | 1.01▼ | 1.07▼ | 1.13▼ | 1.96▼ | 2,556.21▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.000▼ | -0.003▼ | -0.008▼ | 0.178▲ |
| RSI | 22.818▼ | 25.870▼ | 29.550▼ | 35.909▼ | 31.846▼ |
| STOCH | 11.188▼ | 11.068▼ | 11.029▼ | 3.787▼ | 15.987▼ |
| WILL %R | -91.034▼ | -91.559▼ | -91.559▼ | -97.143▼ | -96.518▼ |
| CCI | -54.136 | -54.045 | -54.041 | -89.808 | -90.602 |
|
Sunday, November 30, 2025 10:02 PM
SAN DIEGO, CALIFORNIA / ACCESS Newswire / December 1, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing ...
|
|
Wednesday, November 19, 2025 04:00 PM
SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/12/25 | 0.8699 | 0.8699 | 0.8503 | 0.86 | 53,975 |
| 24/12/25 | 0.862 | 0.89 | 0.86 | 0.8699 | 27,619 |
| 23/12/25 | 0.8601 | 0.8868 | 0.85 | 0.86 | 44,329 |
| 22/12/25 | 0.88 | 0.8899 | 0.85 | 0.8579 | 66,090 |
| 19/12/25 | 0.909 | 0.909 | 0.8671 | 0.8928 | 180,556 |
| 18/12/25 | 0.95 | 0.96 | 0.9005 | 0.9006 | 74,532 |
| 17/12/25 | 0.9579 | 0.9913 | 0.93 | 0.9305 | 104,564 |
| 16/12/25 | 0.96 | 0.993 | 0.95 | 0.9825 | 27,633 |
| 15/12/25 | 1.04 | 1.10 | 0.93 | 0.96 | 132,746 |
| 12/12/25 | 1.19 | 1.19 | 1.01 | 1.05 | 234,512 |
|
|
||||
|
|
||||
|
|